Literature DB >> 16109466

Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution.

Prapasri Sinswat1, Xiaoxia Gao, Miguel J Yacaman, Robert O Williams, Keith P Johnston.   

Abstract

The objective of this study was to investigate the influence of stabilizer type on the physicochemical properties, including dissolution, of ultra-high potency powders containing itraconazole (ITZ) formed by evaporative precipitation into aqueous solution (EPAS). ITZ was dissolved in dichloromethane, which was then atomized through a heated coil at 80 degrees C into an aqueous solution over precise periods of time. Stabilizers were present in either the aqueous, organic or both phases. The dispersions were centrifuged and the supernatant was removed. Three hydrophilic stabilizers were investigated, including polysorbate 80, polyvinyl pyrrolidone and poloxamer 407. Rapid dissolving ultra-high potency of ITZ powders was successfully produced. Greater than 80% of ITZ was dissolved in 5 min compared to only 13% of ITZ bulk powders. The resulting stabilizer-coated drug particles had high drug-to-stabilizer ratios greater than 12, corresponding to potencies (wt drug/wt drug+wt surfactant) as high as 93%. An increase in dissolution rate was correlated with the amount of stabilizer adsorbed and the wettability. The combination of polysorbate 80 and poloxamer 407 present in the aqueous and organic phases, respectively, was superior in achieving high wetting and rapid dissolving ITZ powders. The ability to control the adsorption behavior of stabilizers by using synergistic combinations affords the opportunity to achieve high dissolution rates with higher potencies compared to previously reported values.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109466     DOI: 10.1016/j.ijpharm.2005.06.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.

Authors:  Barbara J Hoeben; David S Burgess; Jason T McConville; Laura K Najvar; Robert L Talbert; Jay I Peters; Nathan P Wiederhold; Bradi L Frei; John R Graybill; Rosie Bocanegra; Kirk A Overhoff; Prapasri Sinswat; Keith P Johnston; Robert O Williams
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.

Authors:  Justin R Hughey; James C DiNunzio; Ryan C Bennett; Chris Brough; Dave A Miller; Hua Ma; Robert O Williams; James W McGinity
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

3.  Formulation and stability testing of itraconazole crystalline nanoparticles.

Authors:  Alia A Badawi; Mohamed Ahmed El-Nabarawi; Doaa Ahmed El-Setouhy; Sami Ahmed Alsammit
Journal:  AAPS PharmSciTech       Date:  2011-06-25       Impact factor: 3.246

4.  Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.

Authors:  Maryam Maghsoodi; Ali Nokhodchi
Journal:  Adv Pharm Bull       Date:  2016-12-22

5.  Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.

Authors:  Stephanie Bosselmann; Masao Nagao; Keat T Chow; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2012-06-30       Impact factor: 3.246

6.  Evaluation of nanodispersion of iron oxides using various polymers.

Authors:  Y Tanaka; H Ueyama; M Ogata; T Daikoku; M Morimoto; A Kitagawa; Y Imajo; T Tahara; M Inkyo; N Yamaguchi; S Nagata
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

7.  Preparation and evaluation of inhalable itraconazole chitosan based polymeric micelles.

Authors:  Esmaeil Moazeni; Kambiz Gilani; Abdolhossein Rouholamini Najafabadi; Mohamad Reza Rouini; Nasir Mohajel; Mohsen Amini; Mohammad Ali Barghi
Journal:  Daru       Date:  2012-12-03       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.